AstraZeneca’s immunotherapy Imfinzi has gained US approval in an important new earlier treatment setting for lung cancer patients. The company announced on Friday that the FDA had approved the ...

There is a commercial access agreement for durvalumab. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

The short report, 'Analysis on the Infiltration Tactics Concerning China's Espionage Cases', released on Sunday noted that the number of people in Taiwan prosecuted for Chinese espionage rose ...

Immunotherapy drug durvalumab, sold under the brand name Imfinzi, could help reduce the risk of bladder cancer progressing or returning to patients, according to a new study. Patients were given ...

Taipei [Taiwan], January 13 (ANI): Taiwan's National Security Bureau (NSB) has released an analysis of China's infiltration tactics, underscoring Beijing's attempts to recruit active service members ...